Covered recipient · General Payments record
SHANTEIA JANEE BEAVERS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$253.06
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $253.06 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $44.13 | 2 |
| PFIZER INC. | $34.91 | 2 |
| Novo Nordisk AS | $34.05 | 2 |
| Sumitomo Pharma America, Inc. | $33.40 | 2 |
| Corium, Inc. | $22.36 | 1 |
| GlaxoSmithKline, LLC. | $19.10 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.54 | 1 |
| Lilly USA, LLC | $16.55 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $16.06 | 1 |
| Acerta Pharma LLC | $14.96 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $253.06 | 14 |
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.96 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104583386 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.54 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086370907 | CMS |
| Corium, LLC | $22.36 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100210566 | CMS |
| Dexcom, Inc. | $22.98 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153386326 | CMS |
| Dexcom, Inc. | $21.15 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153386328 | CMS |
| GlaxoSmithKline, LLC. | $19.10 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116541042 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $16.06 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153736782 | CMS |
| Lilly USA, LLC | $16.55 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135951214 | CMS |
| Novo Nordisk Inc | $17.92 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100554159 | CMS |
| Novo Nordisk Inc | $16.13 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100446455 | CMS |
| PFIZER INC. | $15.09 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131592172 | CMS |
| PFIZER INC. | $19.82 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131629025 | CMS |
| Sumitomo Pharma America, Inc. | $14.52 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148944015 | CMS |
| Sumitomo Pharma America, Inc. | $18.88 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148944017 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.